Overview
The HI100 antibody reacts with an extracellular epitope on the CD45RA isoform of CD45, a type I transmembrane glycoprotein and member of the protein tyrosine phosphatase family (receptor class 1/6 subfamily). Alternative splicing of exons 4, 5, and 6 that encode the extracellular RA, RB, and RC polypeptides of CD45 gives rise to several isoforms with molecular masses of 180 – 240 kDa. Excision of exon 4 generates the ~220-kDa CD45RA isoform, which is expressed on naïve T cells, subsets of B cells and monocytes, and medullary thymocytes. CD45RA functions to enhance signaling through both the T cell receptor and B cell receptor. The HI100 antibody is commonly used in combination with antibodies against the CD45RO isoform to discern naïve and memory T cells and is useful for identifying the suppressor/inducer subset of CD4+ lymphocytes. The proportion of CD45RA+ T cells typically decreases with age.
Subtype: Primary Antibodies
Target Antigen: CD45RA
Alternative Names: B220, CD45, GP180, Lyt-4, Ly-5, LY5, L-CA, LCA, Protein tyrosine phosphatase receptor type C, PTPRC, T200
Reactive Species: Chimpanzee; Human
Conjugation: APC-Cyanine7; Biotin; PE; Unconjugated
Host Species: Mouse
Cell Type: Granulocytes and Subsets; Hematopoietic Stem and Progenitor Cells; Leukocytes; Lymphocytes
Application: CyTOF; ELISA; FACS; Flow Cytometry; Functional Assay; Immunoaffinity Chromatography; Immunocytochemistry; Immunofluorescence; Immunohistochemistry; Immunoprecipitation; Radioimmunoassay; Western Blotting
Area of Interest: Immunology
Clone: HI100
Gene ID: 5788
Isotype: IgG2b, kappa